Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

215
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
215
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

162
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
162
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

290
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
290
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

207
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
207
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

791
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
791

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Growth Differentiation Factor-15 Could Predict Decreased Hemoglobin in Tuberculosis Treated With Linezolid-Containing Regimen.

The clinical respiratory journal·2026
Same author

The ghost of tuberculosis past.

Nature medicine·2026
Same author

Lungs Are Only Half the Story: Programmatic Shifts to Prioritize Pediatric Extrapulmonary Tuberculosis Detection in High-Burden Settings.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Tuberculosis infection tests for contact screening in Brazil: a cost-effectiveness analysis.

Lancet regional health. Americas·2026
Same author

Age and sex differences in paediatric tuberculosis care for child contacts.

Journal of global health·2026
Same author

Diagnostic Performance of New Commercial IGRAs for Mycobacterium tuberculosis Infection: An updated Systematic Review and Meta-analysis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: May 23, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K

結核

Anete Trajman1, Jonathon R Campbell2, Tenzin Kunor3

  • 1Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; McGill International TB Centre, Montreal, QC, Canada.

Lancet (London, England)
|March 8, 2025
PubMed
まとめ
この要約は機械生成です。

結核 (TB) は 世界 的 な 健康 脅威 です. 早期診断と,リスク因子や併発性疾患の管理を含む,個人を中心とした包括的なケアが,この空気感染性疾患の効果的な治療と予防に不可欠です.

さらに関連する動画

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K

関連する実験動画

Last Updated: May 23, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K

科学分野:

  • 世界保健
  • 感染症
  • 呼吸器医学

背景:

  • 結核 (TB) は依然として世界的な死亡原因の1つである.
  • 空気中での感染は 誰にとっても危険です 特に感染頻度が高い地域ではです
  • 栄養不良,免疫抑制,糖尿病などの併発性疾患などの要因によって 活性結核への進行が加速されます.

研究 の 目的:

  • 結核の感染,診断,治療,予防に関する現在の理解をレビューする.
  • 結核と関連する危険因子の管理における人中心のケアの大切さを強調する.
  • 結核の撲滅のための診断と治療の継続的な研究の必要性を強調する.

主な方法:

  • 結核の流行病学,臨床表現,管理戦略に関する現在の文献のレビュー.
  • 唾液検査,分子検査,胸部放射線検査を含む診断方法の分析
  • 治療法,予防方法,併発症と社会的決定因子の管理の役割の検討

主要な成果:

  • 結核の診断には高い疑い指数が必要で,唾液検査とX線写真による迅速な診断が必要である.
  • 効果的な治療には,薬剤耐性結核の短期治療 (≤6ヶ月) が含まれており,薬剤耐性結核の治療期間はより長い.
  • 栄養失調,薬物使用,糖尿病やHIVなどの併発性疾患を 治療する総合的な治療は 治療の成功と長期的な合併症の予防に不可欠です

結論:

  • 結核 の 治療 に 成功 する に は,早期 に 診断 を 行ない,人 に 合わせ た 治療 を 行ない,人 を 中心 に し て 総合 的 な 治療 を 行ない なけれ ば なり ませ ん.
  • 効果的な結核対策と予防には 社会的決定因子と併発症への対処が不可欠です
  • 診断と治療の進歩は 予防戦略の改善とともに 結核の撲滅に不可欠です